Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Clovis Oncology prices

Date Open High Low Close Volume
Nov 02, 2016 $28.51 $28.51 $27.55 $27.96 1 306 200
Nov 01, 2016 $29.20 $29.32 $27.31 $28.53 2 001 200
Oct 31, 2016 $30.41 $30.41 $28.63 $29.08 1 444 300
Oct 28, 2016 $30.68 $31.16 $29.06 $30.58 1 690 400
Oct 27, 2016 $30.78 $32.07 $30.56 $30.87 1 671 500
Oct 26, 2016 $31.00 $32.16 $30.43 $30.62 1 811 800
Oct 25, 2016 $30.00 $31.99 $29.89 $30.40 3 389 200
Oct 24, 2016 $34.01 $34.21 $31.88 $32.31 1 469 600
Oct 21, 2016 $34.18 $34.58 $33.63 $34.24 1 103 000
Oct 20, 2016 $32.30 $34.93 $32.12 $34.47 2 081 300
Oct 19, 2016 $32.92 $33.28 $32.50 $32.60 1 166 100
Oct 18, 2016 $32.25 $33.37 $31.86 $32.93 1 315 100
Oct 17, 2016 $31.32 $32.27 $30.73 $31.85 2 146 000
Oct 14, 2016 $33.20 $33.49 $31.74 $31.81 1 419 900
Oct 13, 2016 $31.97 $33.39 $31.61 $33.12 2 294 500
Oct 12, 2016 $32.53 $33.93 $32.05 $32.68 2 958 700
Oct 11, 2016 $32.08 $33.19 $31.62 $32.58 2 970 000
Oct 10, 2016 $28.01 $32.98 $27.84 $32.44 6 631 700
Oct 07, 2016 $27.56 $31.49 $25.50 $29.41 19 527 800
Oct 06, 2016 $37.07 $37.48 $35.02 $35.77 2 252 600
Oct 05, 2016 $34.61 $38.46 $34.02 $37.28 5 083 500
Oct 04, 2016 $35.76 $36.97 $34.72 $34.76 2 381 500
Oct 03, 2016 $36.20 $36.20 $34.50 $35.35 2 257 400
Sep 30, 2016 $34.65 $36.15 $33.88 $36.05 2 231 900
Sep 29, 2016 $36.12 $36.55 $34.21 $34.64 2 598 500
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT